TaeWoong Medical has secured the US FDA clearance to commercialise the Niti-S Spaxus Stent, expanding its range of EUS-guided therapeutic solutions.
Emily Niespodziany is 40, an age at which many people feel the first tugs of mortality: a sore elbow after a tennis game or ...
healthdigest.com on MSN
Beloved '80s sitcom stars who faced cancer decades later
For better and for worse, celebrities have been influencing the public's attitudes and awareness about cancer, including many stars from '80s TV series.
Reports suggest that Microsoft, one of the industry’s biggest customers, might be taking a step back. Last week, news outlets reported that Microsoft was pausing carbon removal purchases. It was ...
Once held up as a key solution to climate change, a field that aims to remove carbon from the atmosphere is struggling to catch on. By David Gelles David has been writing about carbon removal ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Former Senator Ben Sasse has become an unlikely public face of a drug that researchers are ...
When former Nebraska Sen. Ben Sasse was diagnosed with Stage 4 pancreatic cancer in December, he was given three to four months to live. Now a drug by Revolution Medicines is giving him precious more ...
New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly an earth-shattering moment in pancreatic cancer.” Daraxonrasib, an ...
Nicole Sganga is CBS News' homeland security and justice correspondent. She is based in Washington, D.C., and reports for all shows and platforms. A U.S. special forces soldier involved in the ...
Diabetes is the most common and serious chronic disease worldwide, characterized by insufficient insulin to maintain proper ...
Pancreatic cancer is one of the deadliest cancers. It killed nearly 52,000 Americans last year, many within a year of diagnosis. Now, there are some new experimental medicines with the potential to ...
SAN DIEGO — Experimental therapies with radically different approaches are stirring a wave of optimism that survival rates could substantially improve for pancreatic cancer, one of the most stubbornly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results